|
LSM12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.238200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.84700000000127E-05 |
| Normal-vs-Stage2 |
6.38179999999933E-05 |
| Normal-vs-Stage3 |
4.821300E-03 |
| Normal-vs-Stage4 |
4.089000E-01 |
| Stage1-vs-Stage2 |
3.184800E-01 |
| Stage1-vs-Stage3 |
3.448000E-01 |
| Stage1-vs-Stage4 |
6.620700E-03 |
| Stage2-vs-Stage3 |
1.394810E-01 |
| Stage2-vs-Stage4 |
3.117600E-03 |
| Stage3-vs-Stage4 |
6.688100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.833800E-04 |
| Normal-vs-AfricanAmerican |
1.639660E-04 |
| Normal-vs-Asian |
4.653800E-02 |
| Caucasian-vs-AfricanAmerican |
1.057410E-01 |
| Caucasian-vs-Asian |
4.670000E-01 |
| AfricanAmerican-vs-Asian |
9.348200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.58730000000751E-05 |
| Normal-vs-Female |
3.050000E-02 |
| Male-vs-Female |
6.643800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.683400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.163250E-03 |
| Normal-vs-Age(61-80Yrs) |
6.618200E-04 |
| Normal-vs-Age(81-100Yrs) |
5.598100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.702400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.220800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.354600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.696200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.687600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.318400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.024190E-01 |
| Normal-vs-Grade 2 |
8.07440000000215E-05 |
| Normal-vs-Grade 3 |
3.6847000000062E-06 |
| Normal-vs-Grade 4 |
5.979000E-01 |
| Grade 1-vs-Grade 2 |
8.438000E-01 |
| Grade 1-vs-Grade 3 |
6.063200E-01 |
| Grade 1-vs-Grade 4 |
1.182200E-01 |
| Grade 2-vs-Grade 3 |
3.478000E-01 |
| Grade 2-vs-Grade 4 |
1.431170E-04 |
| Grade 3-vs-Grade 4 |
2.03349999999825E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.49510000000153E-06 |
| Normal-vs-ccB subtype |
2.351900E-02 |
| ccA subtype-vs-ccB subtype |
4.705500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.762200E-03 |
| Normal-vs-N1 |
4.300000E-01 |
| N0-vs-N1 |
2.270100E-02 |
|
|
